Metabolic impact of cardiac hormon therapy

Authors

  • Uriel Pragier Argentine Diabetes Society, Autonomous City of Buenos Aires, Argentina

DOI:

https://doi.org/10.47196/diab.v53i2Sup.227

Keywords:

males, women, hormone therapy

Abstract

Gender dysphoria (DG) implies a discordance between the gender assigned at birth and the self-perceived one. Male transgender or male transsexual (FTM) are identified with the male gender and have been assigned as female at birth. Transgender women or transsexual women (MTF) are identified as women but have been assigned as men at birth. There are those who do not seek extreme masculinization or feminization, which allows the term "sexual diversity" to cover these cases.

References

- Wierckx K, Elaut E, Declercq E, Heylens G, De Cuypere G, Taes Y, Kaufman J, Sjoen G. Prevalence of cardiovascular disease and cancer during cross-sex hormone therapy in a large cohort of trans persons: a case-control study. EJE 2013; 169:471-8.

- Maraka S, Singh N, Rodríguez-Gutiérrez R, Davidge-Pitts C, Nippoldt T, Prokop L, Murad H. Sex steroid and cardiovascular outcomes in transgender individuals: a systematic review and meta-analysis. JCEM Nov 2017; Vol 102, Issue 11. Doi: 10.1210/jc.2017-01643.

- Velho I, Fighera T, Zeigelmann P, Spritzer P. Effects of testosterone therapy on BMI, blood presure, and laboratory profile of transgender men: a systematic review. Andrology 2017 Sep; 5(5):881-888. Doi: 10.1111/andr.12382.

- Nota NM, et al. Ocurrence of acute cardiovascular events in transgender individuals receiving hormonal therapy. Circulation 2019; 139(11):1461-1462.

Downloads

Published

2023-01-10

How to Cite

Pragier, U. (2023). Metabolic impact of cardiac hormon therapy. Journal of the Argentine Society of Diabetes, 53(2Sup), 13. https://doi.org/10.47196/diab.v53i2Sup.227

Issue

Vol. 53 No. 2Sup (2019): May/Agost 2019

Section

Conferences and congresses

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Dirección Nacional de Derecho de Autor, Exp. N° 5.333.129. Instituto Nacional de la Propiedad Industrial, Marca «Revista de la Sociedad Argentina de Diabetes - Asociación Civil» N° de concesión 2.605.405 y N° de disposición 1.404/13.

La Revista de la SAD está licenciada bajo Licencia Creative Commons Atribución – No Comercial – Sin Obra Derivada 4.0 Internacional.

Por otra parte, la Revista SAD permite que los autores mantengan los derechos de autor sin restricciones.